Sterinova Is A Canadian Company Based In Saint Hyacinthequebecthat Specializes In The Developmentmanufacturingand Distribution Of Ready To Use Injectable Pharmaceutical Productsfounded In 2012Sterinova Serves Both Canadian And International Marketsfocusing On Enhancing Patient Care Through Efficient Medication Delivery The Company Offers A Range Of Injectable Medicationsincluding Heparin Sodiumhydromorphone Hydrochloridemidazolammorphine Sulfateand Naloxone Hydrochloridethese Products Are Designed For Healthcare Providers And Institutionssuch As Hospitals And Clinicsthat Require Effective Solutions For Medication Administrationsterinova Has Raised $53 33 Million In Funding And Employs Around 72 Peoplewith Chris Mattes As The President And General Manager
